• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Indapta Partners with Sanofi on Multiple Myeloma Program

    BUSINESSWIRE

    Indapta Presents NK Cell Therapy Data at SITC 2024

    BUSINESSWIRE

    Indapta G-Nk Plenary Featured: Nyas Cancer Immunotherapy Conference

    BUSINESSWIRE

    Indapta Awarded $4.5M By CPRIT For NK Cell Therapy

    BUSINESSWIRE

    Indapta Therapeutics Receives U.S. FDA Fast Track Designation for IDP-023

    BUSINESSWIRE

    Indapta Therapeutics Announces First Patients Treated with IDP-023

    BUSINESSWIRE

    Indapta plans Phase I trial of NK Cell therapy

    CLINICAL TRIALS ARENA

    Indapta Therapeutics Names Moya Daniels, Senior Vice President

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.